In one paragraphArticle in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Alexandra V PodturkinaN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 9, 630090 Novosibirsk, Russia.
Oleg V ArdashovN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 9, 630090 Novosibirsk, Russia.
Yuliya V SoldatovaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Ave. 1, 142432 Chernogolovka, Russia.ORCID 0000-0002-6929-0638 Darya A PoletaevaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Ave. 1, 142432 Chernogolovka, Russia.ORCID 0000-0002-4315-9180 Anastasiya V SmolinaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Ave. 1, 142432 Chernogolovka, Russia.
Ekaterina P VasyuchenkoInstitute for Artificial Intelligence, Lomonosov Moscow State University, Lomonosovsky Ave. 1 Bldg. 27, 119992 Moscow, Russia.ORCID 0000-0003-0972-9378 Yuri V VyatkinInstitute for Artificial Intelligence, Lomonosov Moscow State University, Lomonosovsky Ave. 1 Bldg. 27, 119992 Moscow, Russia.
Nikolai S Li-ZhulanovN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 9, 630090 Novosibirsk, Russia.ORCID 0000-0003-3555-2481 Irina I FaingoldFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Academician Semenov Ave. 1, 142432 Chernogolovka, Russia.ORCID 0000-0003-4926-3859 Nariman F SalakhutdinovN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 9, 630090 Novosibirsk, Russia.
Konstantin P VolchoN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 9, 630090 Novosibirsk, Russia.ORCID 0000-0002-4083-9324 Funding
Russian Science Foundation 24-73-00139
6 · The paper itselfAbstract
Monoamine oxidase B (MAO-B) inhibitors are widely used as part of combination drug therapy for Parkinson's disease. As demonstrated in both in vitro and in vivo experiments, the monoterpenoid Prottremine and some of its derivatives exhibit high antiparkinsonian activity. In this study, the inhibitory activity of Prottremine and its derivatives (including 14 new 9-
Indexed as
Monoamine OxidaseMonoamine Oxidase InhibitorsMonoterpenesAnimalsHumansMiceMolecular Docking SimulationStructure-Activity RelationshipMonoamine OxidaseMonoamine Oxidase InhibitorsMonoterpenesartificial intelligencedockinginhibitorMAOParkinson’s diseaseterpene
Identifiers
PMID39795958
PMCPMC11720030
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390